Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

NVS holding history

Novartis AG in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
12,837
Value
$2.01M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,837$2.01M<0.1%00.0%UnchangedHolders
Q1 202612,837$1.96M<0.1%−223−1.7%ReducedHolders
Q4 202513,060$1.80M<0.1%−202−1.5%ReducedHolders
Q3 202513,262$1.70M<0.1%+10,000+306.6%AddedHolders
Q2 20253,262$394.7K<0.1%−850−20.7%ReducedHolders
Q1 20254,112$458.4K<0.1%+50+1.2%AddedHolders
Q4 20244,062$395.3K<0.1%+899+28.4%AddedHolders
Q3 20243,163$363.8K<0.1%+358+12.8%AddedHolders
Q2 20242,805$298.6K<0.1%00.0%UnchangedHolders
Q1 20242,805$271.3K<0.1%00.0%UnchangedHolders
Q4 20232,805$283.2K<0.1%−150−5.1%ReducedHolders
Q3 20232,955$301.0K<0.1%+525+21.6%AddedHolders
Q2 20232,430$245.2K<0.1%+25+1.0%AddedHolders
Q1 20232,405$221.3K<0.1%−731−23.3%ReducedHolders
Q4 20223,136$284.5K<0.1%−1,553−33.1%ReducedHolders
Q3 20224,689$356.0K<0.1%+1,295+38.2%AddedHolders
Q2 20223,394$287.0K<0.1%−245−6.7%ReducedHolders
Q1 20223,639$319.0K<0.1%+210+6.1%AddedHolders
Q4 20213,429$300.0K<0.1%+402+13.3%AddedHolders
Q3 20213,027$248.0K<0.1%+28+0.9%AddedHolders
Q2 20212,999$274.0K<0.1%−187−5.9%ReducedHolders
Q1 20213,186$272.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.